Quetiapine augmentation in treatment-resistant depression: a naturalistic study

By Šagud Marina   Mihaljević-Peleš Alma   Mück-Šeler Dorotea   Jakovljević Miro   Pivac Nela  

Psychopharmacology, Vol. 187, Iss. 4, 2006-09 ,pp. : 511-514

Springer Publishing Company

Access to resources Recommend Favorite

Case report: successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

By Singh Jaskaran   Zarate Carlos   Krystal Andrew  

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 227-228

Springer Publishing Company

Access to resources Recommend Favorite

Lithium augmentation is associated with further improvement in patients with treatment-resistant depression

By  

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Augmentation therapy with alpha-lipoic acid and desvenlafaxine: A future target for treatment of depression?

By Silva Márcia   Sousa Caren   Sampaio Luis   Ximenes Naiara   Araújo Paulo   Silva Jéssica   Oliveira Suzyana   Sousa Francisca   Macêdo Danielle   Vasconcelos Silvânia  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 386, Iss. 8, 2013-08 ,pp. : 685-695

Springer Publishing Company

Access to resources Recommend Favorite

Use of Dopaminergic Agents in the Treatment-Resistant Depression

By  

Current Psychopharmacology, Vol. 4, Iss. 2, 2016-02 ,pp. : 70-75

Bentham Science Publishers

Access to resources Recommend Favorite